Inhibition of TGF-β signaling by 1D11 antibody treatment increases bone mass and quality in vivo.
Edwards JR, Nyman JS, Lwin ST, Moore MM, Esparza J, O'Quinn EC, Hart AJ, Biswas S, Patil CA, Lonning S, Mahadevan-Jansen A, Mundy GR.
Edwards JR, et al. Among authors: patil ca.
J Bone Miner Res. 2010 Nov;25(11):2419-26. doi: 10.1002/jbmr.139.
J Bone Miner Res. 2010.
PMID: 20499365
Free article.